EU funds lead to new health research methods, survey finds

Dementia and cancer projects surveyed to help Commission choose future impact metrics

A survey of people who received funding for dementia or cancer research from the past four EU R&D programmes has found the most commonly reported benefit was the “development of a new methodology or approach”.

The finding came from a preliminary report from the Joint Research Centre, the European Commission’s evidence service, which is helping the Commission develop ways to gauge the impact of the research the EU funds.